GENE ONLINE|News &
Opinion
Blog

2025-03-19|

Study Links Cigars, Pipes, and Smokeless Tobacco to Increased Heart Disease Risk

by Mark Chiang
Share To

Research has long established the dangers of cigarette smoking, but recent findings highlight that other forms of tobacco use—such as cigars, pipes, and smokeless tobacco—also pose significant risks to heart health. According to data, tobacco use is responsible for nearly one in five deaths annually in the United States. While many fatalities are attributed to cancer, researchers report that individuals who smoke are more likely to die from heart disease than lung cancer.

The study underscores the cardiovascular risks associated with non-cigarette tobacco products. These forms of tobacco consumption have often been perceived as less harmful alternatives; however, evidence suggests they contribute substantially to heart-related illnesses. The findings add to a growing body of research emphasizing the broader health implications of all types of tobacco use beyond their well-documented links to cancer.

Date: 18 March, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Could the Next Global COVID-19 Pandemic Be Spreading Unnoticed, Fueled by Silent Variants?
2025-07-09
Zika Virus Hijacks Human Cells to Supercharge Its Infectious Power
2025-06-02
Peter Marks Steps Down as Head of FDA’s CBER Amid Industry Concerns
2025-03-30
LATEST
Finnish Study Finds Brain Biomarkers for Alzheimer’s Detectable in Middle Age
2025-07-14
Blood Test Developed at Medical University of Vienna Predicts Multiple Sclerosis Risk Years Before Symptoms
2025-07-14
University of Tokyo Researchers Develop In Vivo System to Study Senescent Cells in Aging
2025-07-14
Relmada Therapeutics Ends Development of Depression Drug Esmethadone and Terminates Licensing Agreement
2025-07-14
Takeda Reports Positive Phase 3 Trial Results for Oveporexton in Narcolepsy Treatment
2025-07-14
Takeda Pharmaceuticals Reports Positive Phase 3 Trial Results for Narcolepsy Drug Targeting Daytime Sleepiness and Cataplexy
2025-07-14
Takeda Reports Positive Phase 3 Trial Results for Oveporexton Targeting Orexin Proteins in Narcolepsy Treatment
2025-07-14
EVENT
2025-07-23
BIO Asia–Taiwan 2025
Taipei, Taiwan
2025-08-08
HEALTHY AGEING TECH SHOW
Taipei, Taiwan
2025-08-09
MEDINFO 2025
Taipei, Taiwan
2025-09-03
BIO ASIA PACIFIC 2025
Bangkok, Thailand
2025-09-10
BIOHK 2025
Hong Kong
2025-10-01
Medical Japan 2025
Osaka, Japan
Scroll to Top